Biomarin Pharmaceutical Inc (BMRN) — Financial Flexibility Index
Biomarin Pharmaceutical Inc (BMRN) has a Financial Flexibility Index of 0.10x as of March 2026. Free cash flow of $241.57 Million (operating CF $220.65 Million minus capex $20.92 Million) represents 0% of total liabilities ($2.38 Billion). Check BMRN capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biomarin Pharmaceutical Inc Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Biomarin Pharmaceutical Inc across 28 annual periods. See BMRN working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Biomarin Pharmaceutical Inc (1998–2025)
Year-by-year free cash flow to debt coverage for Biomarin Pharmaceutical Inc. For the full company profile including market capitalisation, see market cap of Biomarin Pharmaceutical Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | $931.03 Million | $827.99 Million | $1.51 Billion | ▲ +22.7% |
| 2024 | 0.50x | $670.26 Million | $572.84 Million | $1.33 Billion | ▲ +271.9% |
| 2023 | 0.14x | $255.95 Million | $159.26 Million | $1.89 Billion | ▼ -19.2% |
| 2022 | 0.17x | $296.86 Million | $175.90 Million | $1.77 Billion | ▼ -31.5% |
| 2021 | 0.24x | $423.76 Million | $304.54 Million | $1.73 Billion | ▲ +91.2% |
| 2020 | 0.13x | $222.88 Million | $85.36 Million | $1.74 Billion | ▲ +3.8% |
| 2019 | 0.12x | $193.29 Million | $48.26 Million | $1.57 Billion | ▲ +9.2% |
| 2018 | 0.11x | $164.83 Million | $20.21 Million | $1.46 Billion | ▲ +8.2% |
| 2017 | 0.10x | $190.46 Million | $-8.76 Million | $1.82 Billion | ▲ +265.2% |
| 2016 | -0.06x | $-79.46 Million | $-227.84 Million | $1.26 Billion | ▼ -1507.6% |
| 2015 | 0.00x | $5.96 Million | $-221.69 Million | $1.33 Billion | ▼ -90.5% |
| 2014 | 0.05x | $45.30 Million | $-73.54 Million | $962.56 Million | ▲ +674.0% |
| 2013 | 0.01x | $5.49 Million | $-59.63 Million | $903.02 Million | ▼ -94.6% |
| 2012 | 0.11x | $62.18 Million | $17.61 Million | $552.58 Million | ▼ -65.3% |
| 2011 | 0.32x | $172.97 Million | $18.75 Million | $532.66 Million | ▲ +159.6% |
| 2010 | 0.13x | $68.21 Million | $18.75 Million | $545.37 Million | ▼ -58.1% |
| 2009 | 0.30x | $177.53 Million | $87.73 Million | $594.98 Million | ▲ +298.3% |
| 2008 | 0.07x | $47.19 Million | $-9.18 Million | $630.02 Million | ▲ +489.1% |
| 2007 | -0.02x | $-12.08 Million | $-34.49 Million | $627.55 Million | ▲ +73.9% |
| 2006 | -0.07x | $-25.51 Million | $-50.09 Million | $345.63 Million | ▲ +66.3% |
| 2005 | -0.22x | $-59.72 Million | $-62.68 Million | $272.76 Million | ▼ -60.5% |
| 2004 | -0.14x | $-41.07 Million | $-65.14 Million | $300.94 Million | ▲ +72.5% |
| 2003 | -0.50x | $-68.82 Million | $-74.80 Million | $138.49 Million | ▲ +87.7% |
| 2002 | -4.04x | $-48.73 Million | $-53.59 Million | $12.07 Million | ▼ -842.3% |
| 2001 | -0.43x | $-5.25 Million | $-23.07 Million | $12.26 Million | ▲ +67.5% |
| 2000 | -1.32x | $-9.14 Million | $-12.90 Million | $6.94 Million | ▼ -168.1% |
| 1999 | 1.93x | $10.00 Million | $-12.94 Million | $5.17 Million | ▲ +340.1% |
| 1998 | -0.81x | $-1.70 Million | $-8.10 Million | $2.11 Million | — |